Sunrun Inc

Rule 10b5-1 Disclosure

During our last fiscal quarter, some of our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted orterminated the contracts, instructions or written plans for the purchase or sale of our securities as noted below.

On May 10, 2024, Mary Powell, our Chief Executive Officer and a member of our Board, terminated a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan was set to expire on December 31, 2024 and provided for the sale of up to 6,463 shares of common stock, subject to the Company’s stock price reaching a certain price threshold.

On May 13, 2024, Gerald Risk, a member of our Board, adopted a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan is set to expire on July 31, 2025 and provides for the sale of up to 36,180 shares of common stock, which is based upon the Company's stock price reaching certain price thresholds.

On May 17, 2024, Paul Dickson, our President and Chief Revenue Officer, terminated a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan was set to expire on February 20, 2025 and provided for the following transactions, each of which was based upon the Company’s stock price reaching certain price thresholds: (i) the exercise of up to 55,067 stock options and the sale of the underlying shares of common stock, and (ii) the sale of up to 59,734 shares of common stock. Subsequently on May 17, 2024, Mr. Dickson adopted a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan is set to expire on August 15, 2025 and provides for the following transactions, each of which is subject to the Company's stock price reaching certain price thresholds: (i) the exercise of up to 140,250 stock options and the sale of the underlying shares of common stock, and (ii) the sale of up to 63,266 shares of common stock.

On June 3, 2024, Danny Abajian, our Chief Financial Officer, terminated a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan was set to expire on May 30, 2025 and provided for the following transactions, each of which was based upon the Company’s stock price reaching certain price thresholds: (i) the exercise of up to 155,374 stock options and the sale of the underlying shares of common stock, and (ii) the sale of up to 141,965 shares of common stock. Subsequently on June 3, 2024, Mr. Abajian adopted a trading plan for the sale of the Company’s common stock that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan is set to expire on June 2, 2026 and provides for the following transactions, each of which is subject to the Company's stock price reaching certain price thresholds: (i) the exercise of up to 200,782 stock options and the sale of the underlying shares of common stock, and (ii) the sale of up to 156,641 shares of common stock.